Potentially Inappropriate Prescribing of Primarily Renally Cleared Medications for Older Veterans Affairs Nursing Home Patients

Journal of the American Medical Directors Association

Volumn 12, Issue 5, 2011, Pages 377-383

  Hanlon, Joseph T ^a,b,c,d,e   Wang, Xiaoqiang ^e   Handler, Steven M ^a,d,e   Weisbord, Steven ^a,e   Pugh, Mary Jo ^f   Semla, Todd ^g,h   Stone, Roslyn A ^b,e   Aspinall, Sherrie L ^c,e,g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Center for Health Equity Research and Promotion   (United States)

^f Veterans Evidence Based Research Dissemination and Implementation Center   (United States)

^g DEPARTMENT OF VETERANS AFFAIRS   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMANTADINE; CHLORPROPAMIDE; CIPROFLOXACIN; COLCHICINE; COTRIMOXAZOLE; DEXTROPROPOXYPHENE; DULOXETINE; ETIRACETAM; GABAPENTIN; GLIBENCLAMIDE; MEMANTINE; NITROFURANTOIN; PETHIDINE; PROBENECID; RANITIDINE; RIMANTADINE; SPIRONOLACTONE; TRAMADOL; TRIAMTERENE; VALACICLOVIR;

AGED; AGING; ARTICLE; BODY MASS; COMORBIDITY; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG CONTRAINDICATION; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESCRIPTION; TREATMENT OUTCOME; VETERANS HEALTH;

EID: 79956268071     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.04.008     Document Type: Article

References (40)

1. McCellan W.M., Resnick B., Lei L., et al. Prevalence and severity of chronic kidney disease and anemia in the nursing home population. J Am Med Dir Assoc 2010, 11:33-41.
2. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Eng J Med 2006, 354:2473-2483.
3. Stevens L.A., Levey A.S. Chronic kidney disease in the elderly-how to assess risk. N Eng J Med 2005, 352:2122-2124.
4. Chan R., Michelis M.F. Nephrologic complications of drug therapy in the elderly. Geriatr Nephrol Urol 1998, 8:29-44.
5. Schetz M., Dasta J., Goldstein S., Golper T. Drug-induced acute kidney disease. Cur Opin Crit Care 2005, 11:555-565.
6. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266. National Kidney Foundation (NFK).
7. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
8. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Ann Intern Med 2003, 139:137-147.
9. Papaioannou A., Clarke J.A., Campbell G., Bedard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000, 48:1470-1473.
10. Rahimi A.R., Kennedy K., Thomason M., et al. Improper renal dosing in long-term care facilities. South Med J 2008, 101:802-805.
11. Vidal L., Shavit M., Fraser A., et al. Systematic comparison of drug information regarding adjustment of dose for renal function. BMJ 2005, 331:263-266.
12. Stevens L.A., Nolin T.D., Richardson M.M., et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009, 54:33-42.
13. Spruill W.J., Wade W.E., Cobb H.H. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009, 86:468-470.
14. Hanlon J.T., Wang X., Good C.B., et al. Racial differences in medication use among older long stay veteran nursing home care unit patients. Consult Pharm 2009, 24:439-446.
15. Mor V. A comprehensive clinical assessment tool to inform policy and practice: applications of the Minimum Data Set. Med Care 2004, 42:III50-III59.
16. Cockcroft D.W., Gault M.H. Predicting creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
17. Hanlon J.T., Aspinall S., Semla T., et al. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009, 57:335-340.
18. VA/DOD Clinical practice guidelines. Management of Chronic Kidney Disease (CKD) in Critical Care. Available at: Accessed November 13, 2009. http://www.healthquality.va.gov/Chronic_Kidney_Disease_Clinical_Practice_Guideline.asp.
19. National Heart, Lung, and Blood Institute (NHLBI). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults 1998. Available at: Accessed November 11, 2009. http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm.
20. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
21. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
22. McConnell E.S., Pieper C.F., Sloane R.J., et al. Effects of cognitive performance on change in physical function in long-stay nursing home residents. J Gerontol 2002, 57:M778-M784.
23. Psaty B.M., Koepsell T.D., Lin D., et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999, 47:749-754.
24. Hartmaier S.L., Sloane P.D., Guess H.A., et al. Validation of the Minimum Data Set Cognitive Performance Scale: Agreement with the Mini-Mental State Examination. J Gerontol 1995, 50:M128-M133.
25. Burrows A.B., Morris J.N., Simon S.E., et al. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 2000, 29:165-172.
26. Hosmer D.W., Lemeshow S. Applied Logistic Regression 2000, Wiley, New York, NY. 2nd ed.
27. Hanlon J.T., Landerman L.R., Artz M.B., et al. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Pharmacoepidemiol Drug Saf 2004, 13:781-787.
28. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996, 44:751-755.
29. van Staa T., Abenhaim L., Monette J. Rates of hypoglycaemia in users of sulphonylureas. J Clin Epidemiol 1997, 50. 745-741.
30. Charpentier G., Riveline J.P., Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab 2000, 26:73-85.
31. Ganji A.S., Cukierman T., Gerstein H.C., et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events. A comparison of glyburide with other secretagogues and with insulin. Diabetes Care 2007, 30:389-394.
32. Lindblad C.I., Artz M.B., Pieper C.F., et al. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 2005, 39:412-417.
33. Hanlon J.T., Artz M.B., Pieper C.F., et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004, 38:9-14.
34. Huang S.M., Temple R., Xiao S., et al. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective. Clin Pharmacol Ther 2009, 86:475-479.
35. Demirovic J.A., Pai A.B., Pai M.P. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm 2009, 66:642-648.
36. National Kidney Disease Education Program (NKDEP) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Kidney Disease and Drug Dosing: Information for Providers (Revised January 2010). Available at: Accessed April 16, 2010. http://www.nkdep.nih.gov/professionals/CKD_DrugDosing_508.pdf.
37. Stevens L.A., Nolin T., Richardson M., et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009, 54:33-42.
38. Dowling T.C., Matzke G.R., Murphy J.E. Estimated GFR vs creatinine clearance for drug dosing. Am J Kidney Dis 2009, 54:984-985.
39. Roberts G.W., Ibsen P.M., Schiøler C.T. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009, 38:698-703.
40. Olyaei A.J., Bennett W.M. Drug dosing in elderly patients with chronic kidney disease. Clin Geriatr Med 2009, 25:459-527.